Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAURA SPYCHE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1760511034
CMS profile
11250063
Location
CHEEKTOWAGA, NY

General Payments · PY2021–2024

$24,282.31

  • Reported across 200 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,237.28

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Honoraria $4,500.00 3
Food and Beverage $486.07 21
Travel and Lodging $210.38 2
Education $40.83 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Fresenius USA Marketing, Inc. $4,871.07 9
Retrophin, Inc. $122.92 14
Acerta Pharma LLC $85.22 5
Bayer HealthCare Pharmaceuticals Inc. $45.49 2
Lilly USA, LLC $38.69 2
Phathom Pharmaceuticals, Inc. $29.14 1
Amgen Inc. $25.56 1
Kyowa Kirin, Inc. $19.19 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $9,011.82 56
PY2022 $8,932.12 49
PY2023 $1,101.09 60
PY2024 $5,237.28 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $25.56 03/20/2024 Food and Beverage Undisputed 01/23/2026 1117389810 CMS
AstraZeneca Pharmaceuticals LP $13.86 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105626749 CMS
AstraZeneca Pharmaceuticals LP $19.83 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105240669 CMS
AstraZeneca Pharmaceuticals LP $15.61 02/14/2024 Food and Beverage Undisputed 01/23/2026 1104677779 CMS
AstraZeneca Pharmaceuticals LP $13.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105515099 CMS
AstraZeneca Pharmaceuticals LP $22.22 04/04/2024 Food and Beverage Undisputed 01/23/2026 1104550850 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.80 01/10/2024 Food and Beverage Undisputed 01/23/2026 1086291260 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.69 02/21/2024 Food and Beverage Undisputed 01/23/2026 1086355618 CMS
Fresenius USA Marketing, Inc. $23.53 03/18/2024 Food and Beverage Undisputed 01/23/2026 1154194858 CMS
Fresenius USA Marketing, Inc. $118.16 03/26/2024 Food and Beverage Undisputed 01/23/2026 1154194864 CMS
Fresenius USA Marketing, Inc. $2,000.00 04/08/2024 Honoraria Undisputed 01/23/2026 1154194850 CMS
Fresenius USA Marketing, Inc. $2,000.00 04/08/2024 Honoraria Undisputed 01/23/2026 1154194852 CMS
Fresenius USA Marketing, Inc. $100.50 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1154194860 CMS
Fresenius USA Marketing, Inc. $109.88 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1154194862 CMS
Fresenius USA Marketing, Inc. $14.74 04/10/2024 Food and Beverage Undisputed 01/23/2026 1154194856 CMS
Fresenius USA Marketing, Inc. $500.00 07/19/2024 Honoraria Undisputed 01/23/2026 1154194866 CMS
Fresenius USA Marketing, Inc. $4.26 07/31/2024 Food and Beverage Undisputed 01/23/2026 1154194854 CMS
Kyowa Kirin, Inc. $19.19 03/27/2024 Food and Beverage Undisputed 01/23/2026 1127052579 CMS
Lilly USA, LLC $20.12 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135750967 CMS
Lilly USA, LLC $18.57 04/17/2024 Food and Beverage Undisputed 01/23/2026 1135763051 CMS
Phathom Pharmaceuticals, Inc. $29.14 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151207541 CMS
Travere Therapeutics, Inc. $3.08 01/08/2024 Education Undisputed 01/23/2026 1149884857 CMS
Travere Therapeutics, Inc. $19.41 01/08/2024 Food and Beverage Undisputed 01/23/2026 1149884905 CMS
Travere Therapeutics, Inc. $3.08 01/17/2024 Education Undisputed 01/23/2026 1149884861 CMS
Travere Therapeutics, Inc. $3.08 01/25/2024 Education Undisputed 01/23/2026 1149884865 CMS
Travere Therapeutics, Inc. $3.08 02/19/2024 Education Undisputed 01/23/2026 1149884869 CMS
Travere Therapeutics, Inc. $13.50 02/19/2024 Food and Beverage Undisputed 01/23/2026 1149884885 CMS
Travere Therapeutics, Inc. $3.08 03/13/2024 Education Undisputed 01/23/2026 1149884873 CMS
Travere Therapeutics, Inc. $18.49 03/13/2024 Food and Beverage Undisputed 01/23/2026 1149884901 CMS
Travere Therapeutics, Inc. $2.38 05/01/2024 Education Undisputed 01/23/2026 1149884853 CMS
Travere Therapeutics, Inc. $14.13 05/01/2024 Food and Beverage Undisputed 01/23/2026 1149884889 CMS
Travere Therapeutics, Inc. $3.08 05/15/2024 Education Undisputed 01/23/2026 1149884877 CMS
Travere Therapeutics, Inc. $3.08 06/05/2024 Education Undisputed 01/23/2026 1149884881 CMS
Travere Therapeutics, Inc. $16.56 08/21/2024 Food and Beverage Undisputed 01/23/2026 1149884893 CMS
Travere Therapeutics, Inc. $16.89 08/30/2024 Education Undisputed 01/23/2026 1149884897 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.